Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
Contents:; Best Practices for Successful Engagement -- Diversity in Patient Engagement -- Engagement Methods -- How to Request Patient and Family Partners -- Matching Partners -- Planning Engagement -- Presenting With Patient Partners -- Reimbursing Partners.
A 2020 special report on lung cancer
A 2018 special report on cancer incidence by stage
Living with Cancer: A Report on the Patient Experience, is the first in a series looking at Canadian cancer care exclusively from the patient perspective, illustrating the experience of those individuals and families living with and beyond cancer. This groundbreaking report includes data drawn from…
CIHI's report Access to Palliative Care in Canada provides baseline information on what we know about palliative care services in the last year of life, on whether Canadians have equitable and timely access to appropriate services and on gaps in this area of health care. - Website
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Special topic: Pancreatic cancer
Report references: The Bow Tie Model of 21st Century Palliative Care by Dr. Pippa Hawley, January 2015:; http://www.virtualhospice.ca/en_US/Main+Site+Navigation/Home/For+Professionals/For+Professionals/The+Exchange/Current/The+Bow+Tie+Model+of+21st+Century+Palliative+Care.aspx.; Accompanying report…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | On Loan, due Tuesday, January 9, 2024 | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |